Our HPLC columns have been designed and manufactured by Imtakt Corporation with exceptional craftsmanship and decades of industry experience.
Company Description
Our HPLC columns have been designed and manufactured by Imtakt Corporation with exceptional craftsmanship and decades of industry experience. Our columns give chromatographers:
Chief Chromatographic Techniques Supported
Markets Served
All LC and LC–MS markets including: pharmaceutical, biotech, contract research, forensic, clinical diagnostic, food and beverage, industrial, chemical, environmental, and academic research.
Major Products/Services
Below is a sample of some HPLC column phases from Imtakt:
Facilities
We are located in Philadelphia, Pennsylvania and deliver next day for 95% of North American orders and always within one week.
Imtakt USA
1511 Walnut Street, Suite 310
Philadelphia, PA 19102
TELEPHONE
(215) 665-8902
FAX
(501) 646-3497
WEB SITE
YEAR FOUNDED
2004
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Metabolomics Analysis of Low Birth-Weight Infants Using UHPLC-MS/MS Following Lipid Emulsion
January 10th 2025A recent study aimed to directly compare the changes in serum metabolites among very low birth-rate (VLBW) infants following the administration of the soybean oil-based lipid emulsion and soybean oil, medium-chain triglycerides, olive oil, and fish oil (SMOF) lipid emulsion using untargeted metabolomics techniques.
Analyzing New Drug Modalities: An ISC 2024 Interview with Kelly Zhang
January 10th 2025At ISC 2024 in Liverpool, United Kingdom, LCGC International interviewed Kelly Zhang of Genentech about her work analyzing new drug modalities, such as mRNA, oligonucleotides, peptides, and cell and gene therapies.